Positive diabetes drug data triggers $20M payday for Zealand; Opsona names new CEO;

@FierceBiotech: Soligenix' proprietary vaccine thermostabilization technology passed through preclinical proof-of-concept studies. Release | Follow @FierceBiotech

@JohnCFierce: Celgene pays $15M for front-row seat on Acetylon myeloma program. Article | Follow @JohnCFierce

@FierceMedDev: EU wants more medical device controls after PIP scare. News via @Reuters | Follow @FierceMedDev

@MarkHFierce: A U.S. trial will test umbilical cord stem cells to treat /reverse hearing loss in babies. It worked in mice. More | Follow @MarkHFierce

> FDA rewards Roche with priority review for blockbuster cancer drug. News

> Copenhagen-based Zealand Pharma has earned a $20 million milestone with the successful completion of Sanofi's late-stage program for the diabetes drug lixisenatide. Release

> Alexion has closed on its deal to buy Enobia for $1.1 billion. Story

> Dr. Martin Welschof, previously managing director of Affitech, has taken the helm at Dublin-based Opsona Therapeutics as its new CEO. Conor Dalton, previously VP finance and chief accounting officer for Amarin, has joined Opsona as director of finance. Release

> Germany's Proteros biostructures announced that Dr. Klaus Hinterding, formerly at Roche, has joined the company as chief scientific officer. Release

Pharma News

@FiercePharma: Shire reports an enviable 47% spike in Q4 earnings, thanks to ADHD and rare-disease meds. Release | Follow @FiercePharma

> FDA panel nixes new use for Amgen's Xgeva. Article

> Watson chief has big brand plans for $6B war chest. Story

> Judge: No 1st Amendment shield for Astellas' Prograf petition. News

CRO News

> AZ's China R&D strategy calls for outsourcing. Item

> Takeda opens new drug development center in China. Article

> Quintiles report highlights the challenge of the 'value proposition.' Report

> AstraZeneca's latest restructuring spurs debate over outsourcing R&D. Story

> United Drug nails $40M pharma outsourcing contract. Piece

Vaccines News

> Merck's RotaTeq not linked with bowel problems. More

> Novartis' Bexsero successfully protects vast majority of infants. Article

> Researchers target vaccines for the First Nation. Story

> Hints of a heroin vaccine from Mexico. News

> Bacterial cancer vaccines show glimpses of activity. Piece

Manufacturing News

> Pakistan Supreme Court interjects itself in drug death scandal. News

> Being more like Coca-Cola takes days out of GSK's pharma supply chain. More

> Decision on new GSK plant location to come soon. Item

> ViroPharma responding quickly to FDA delay of Cinryze manufacturing expansion. Piece

And Finally... A group of epilepsy patients say electrical currents sent through their brains helped improve memory, suggesting that deep brain stimulation may help treat Alzheimer's and other ailments. Story

Suggested Articles

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.

The biotech began testing the small molecule in a phase 3 trial of heavily pretreated small cell lung cancer patients late last year. 

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.